Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

624

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Postoperative Nausea and VomitingNausea and Vomiting, Postoperative
Interventions
DRUG

GW597599

Trial Locations (55)

1070

GSK Investigational Site, Brussels

1200

GSK Investigational Site, Brussels

2065

GSK Investigational Site, St Leonards

2145

GSK Investigational Site, Westmead

3000

GSK Investigational Site, Leuven

3004

GSK Investigational Site, Melbourne

3128

GSK Investigational Site, Ringwood East

3186

GSK Investigational Site, Carlton

6008

GSK Investigational Site, Subiaco

9000

GSK Investigational Site, Ghent

9301

GSK Investigational Site, Bloemfontein

10021

GSK Investigational Site, New York

12208

GSK Investigational Site, Albany

19141

GSK Investigational Site, Philadelphia

27609

GSK Investigational Site, Raleigh

27710

GSK Investigational Site, Durham

33067

GSK Investigational Site, Boca Raton

34303

GSK Investigational Site, Istanbul

60611

GSK Investigational Site, Chicago

68131

GSK Investigational Site, Omaha

70210

GSK Investigational Site, Kuopio

72205

GSK Investigational Site, Little Rock

77024

GSK Investigational Site, Houston

90048

GSK Investigational Site, Los Angeles

90089

GSK Investigational Site, Los Angeles

91109

GSK Investigational Site, Pasadena

91206

GSK Investigational Site, Glendale

95660

GSK Investigational Site, Laguna Hills

99204

GSK Investigational Site, Spokane

7571831

GSK Investigational Site, Santiago

8380456

GSK Investigational Site, Santiago

75390-9135

GSK Investigational Site, Dallas

V8Z 6R5

GSK Investigational Site, Victoria

B3H 2Y9

GSK Investigational Site, Halifax

P3E 5V9

GSK Investigational Site, Greater Sudbury

K7L 2V7

GSK Investigational Site, Kingston

L1G 2B9

GSK Investigational Site, Oshawa

C1A 8T5

GSK Investigational Site, Charlottetown

G0C 1K0

GSK Investigational Site, Chandler

S4P 0W5

GSK Investigational Site, Regina

625 00

GSK Investigational Site, Brno

586 33

GSK Investigational Site, Jihlava

775 20

GSK Investigational Site, Olomouc

708 52

GSK Investigational Site, Ostrava - Poruba

00029

GSK Investigational Site, Helsinki

4708 AE

GSK Investigational Site, Roosendaal

3011 TD

GSK Investigational Site, Rotterdam

3083 AN

GSK Investigational Site, Rotterdam

60-535

GSK Investigational Site, Poznan

02-507

GSK Investigational Site, Warsaw

02-781

GSK Investigational Site, Warsaw

0083

GSK Investigational Site, Arcadia, Pretoria

Unknown

GSK Investigational Site, Istanbul

CM1 7ET

GSK Investigational Site, Chelmsford

NN1 5BD

GSK Investigational Site, Northampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY